ATE323149T1 - Paramyxovirus-vektor zum gentransfer ins kardiovaskuläre system - Google Patents

Paramyxovirus-vektor zum gentransfer ins kardiovaskuläre system

Info

Publication number
ATE323149T1
ATE323149T1 AT01981031T AT01981031T ATE323149T1 AT E323149 T1 ATE323149 T1 AT E323149T1 AT 01981031 T AT01981031 T AT 01981031T AT 01981031 T AT01981031 T AT 01981031T AT E323149 T1 ATE323149 T1 AT E323149T1
Authority
AT
Austria
Prior art keywords
cardiovascular system
vector
gene transfer
paramyxovirus vector
paramyxovirus
Prior art date
Application number
AT01981031T
Other languages
English (en)
Inventor
Uta Griesenbach
Stefano Ferrari
Duncan M Geddes
Eric Wfw Alton
Mamoru Hasegawa
Xiaogang Hou
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Application granted granted Critical
Publication of ATE323149T1 publication Critical patent/ATE323149T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01981031T 2000-11-08 2001-11-08 Paramyxovirus-vektor zum gentransfer ins kardiovaskuläre system ATE323149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000339942A JP2002142770A (ja) 2000-11-08 2000-11-08 循環系への遺伝子送達用パラミクソウイルスベクター

Publications (1)

Publication Number Publication Date
ATE323149T1 true ATE323149T1 (de) 2006-04-15

Family

ID=18814933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01981031T ATE323149T1 (de) 2000-11-08 2001-11-08 Paramyxovirus-vektor zum gentransfer ins kardiovaskuläre system

Country Status (12)

Country Link
US (1) US20040101965A1 (de)
EP (2) EP1334174B1 (de)
JP (1) JP2002142770A (de)
KR (1) KR100852078B1 (de)
CN (1) CN1555417B (de)
AT (1) ATE323149T1 (de)
AU (1) AU2002212733A1 (de)
CA (1) CA2428073C (de)
DE (1) DE60118771T2 (de)
DK (1) DK1334174T3 (de)
ES (1) ES2260301T3 (de)
WO (1) WO2002038726A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6490775B1 (en) * 1999-04-23 2002-12-10 Veri-Tek Inc. Press operation verification system
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
CA2376106A1 (en) 1999-09-06 2001-03-15 Dnavec Research Inc. Paramyxoviruses comprising modified transcription start sequence
US7314614B1 (en) 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
KR100854917B1 (ko) 2000-03-30 2008-08-27 가부시키가이샤 디나벡크 겐큐쇼 센다이바이러스 벡터를 사용한 ａｉｄｓ 바이러스 백신
AU2001262684A1 (en) * 2000-06-01 2001-12-11 Dnavec Research Inc. Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity
AU2001266337A1 (en) * 2000-06-27 2002-01-08 Dnavec Research Inc. Virus vector for transferring gene into renal cells
CN1526014A (zh) * 2000-10-06 2004-09-01 ��ʽ���������о��� 用于将外源基因导入骨骼肌的副粘病毒载体
ES2305138T3 (es) 2000-11-27 2008-11-01 Dnavec Research Inc. Vector de paramixovirus que codifica factor 2 de crecimiento de fibroblastos (fgf2) y uso del mismo.
EP1504766A4 (de) * 2002-04-30 2006-11-02 Dnavec Research Inc Arzneimittel- oder genträgerzusammensetzung mit verringerter hämagglutinin-aktivität
US20060128019A1 (en) * 2002-09-04 2006-06-15 Masanori Kobayashi Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase
WO2004038029A1 (ja) * 2002-10-24 2004-05-06 Dnavec Research Inc. T細胞に遺伝子を導入する方法
JPWO2005001082A1 (ja) * 2003-06-30 2006-08-10 株式会社ディナベック研究所 高変異領域が改変された遺伝子を搭載するマイナス鎖ｒｎａウイルスベクター
JPWO2005067981A1 (ja) * 2004-01-13 2007-12-27 株式会社ディナベック研究所 免疫刺激性サイトカインをコードするマイナス鎖ｒｎａウイルスベクターを用いる腫瘍の遺伝子治療
KR20070004637A (ko) * 2004-01-22 2007-01-09 가부시키가이샤 디나벡크 겐큐쇼 바이러스 벡터의 제조방법
CN1957084A (zh) * 2004-03-23 2007-05-02 株式会社载体研究所 与组织的维持和/或修复相关联的骨髓相关细胞
EP1891215B1 (de) * 2005-04-20 2009-10-28 Dnavec Corporation Hochsichere intranasal verabreichbare genimpfstoffe zur behandlung von morbus alzheimer
JP4969444B2 (ja) * 2005-06-14 2012-07-04 ディナベック株式会社 抗体の作製方法
DK1950307T3 (en) 2005-10-28 2016-02-15 Id Pharma Co Ltd Luftvejsepitelstamcelle for gene transfer using a lentiviral vector, which is pseudo typified by RNA virus spike protein
EP1983048A4 (de) * 2006-01-17 2009-04-22 Dnavec Corp Neues proteinexpressionssystem
CN105209054A (zh) 2013-04-18 2015-12-30 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
JP2016528879A (ja) 2013-06-17 2016-09-23 アルモ・バイオサイエンシーズ・インコーポレイテッド タンパク質の同一性および安定性を評価する方法
HK1226308A1 (zh) 2013-08-30 2017-09-29 Armo Biosciences, Inc. 使用白细胞介素-10治疗疾病和病症的方法
US11413332B2 (en) 2013-11-11 2022-08-16 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) * 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
JP6675394B2 (ja) 2014-10-22 2020-04-01 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害の治療のためにインターロイキン−１０を使用する方法
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
JP7053453B2 (ja) 2015-08-25 2022-04-12 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害を治療するためのインターロイキン１０の使用方法

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155214A (en) * 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
JPS6147185A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147186A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147187A (ja) 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
US4994559A (en) * 1985-12-17 1991-02-19 Synergen, Inc. Human basic fibroblast growth factor
US5215745A (en) * 1988-04-27 1993-06-01 United Cancer Research Institute Method for treating viral diseases with attenuated virus
US5670488A (en) * 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5827513A (en) * 1990-06-29 1998-10-27 Schering Corporation Methods of treating insulin-dependent diabetes mellitus by administration of IL-10
US5631237A (en) * 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
US6562596B1 (en) * 1993-10-06 2003-05-13 Amgen Inc. Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
US5635380A (en) * 1994-01-18 1997-06-03 Vanderbilt University Enhancement of nucleic acid transfer by coupling virus to nucleic acid via lipids
US5639661A (en) * 1994-03-23 1997-06-17 The University Of Iowa Research Foundation Genes and proteins for treating cystic fibrosis
DK0702085T4 (da) * 1994-07-18 2010-04-06 Conzelmann Karl Klaus Prof Dr Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
US5824655A (en) * 1995-02-15 1998-10-20 The University Of Utah Anti-transforming growth factor-β gene therapy
US5744304A (en) * 1995-05-30 1998-04-28 Board Of Regents, The University Of Texas System Inflammation-induced expression of a recombinant gene
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US6121246A (en) * 1995-10-20 2000-09-19 St. Elizabeth's Medical Center Of Boston, Inc. Method for treating ischemic tissue
DE69634904T2 (de) * 1995-10-31 2006-05-18 Dnavec Research Inc., Tsukuba Negativstrand rna virus mit selbständiger replikationsaktivität
CN1143892C (zh) * 1995-11-01 2004-03-31 株式会社载体研究所 重组仙台病毒
JP4223550B2 (ja) 1996-02-29 2009-02-12 タカラバイオ株式会社 ウイルスの精製および除去方法
US5833651A (en) * 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
JP3959117B2 (ja) * 1996-12-16 2007-08-15 エーザイ・アール・アンド・ディー・マネジメント株式会社 遺伝子治療用レトロウイルスベクターの作製法
CA2205076A1 (en) * 1997-05-14 1998-11-14 Jim Hu Episomal expression cassettes for gene therapy
FR2766706B1 (fr) * 1997-07-30 2001-05-25 Biovector Therapeutics Sa Complexes particulaires stables de charge globale neutre ou negative de structure multilamellaire composes par au moins une substance biologiquement active globalement anionique et un constituant cationique, leur preparation et utilisation
US5962274A (en) * 1998-03-13 1999-10-05 Wake Forest University Viral vector directed to predetermined target cells
US6828138B1 (en) * 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
EP1013667B1 (de) * 1998-11-09 2006-10-11 Nippon Biologicals, Inc. Verfahren zur Cytokinproduktionn unter Verwendung eines Sendai Virus Expressionssystems
JP2000201689A (ja) * 1998-11-09 2000-07-25 Nippon Bio Capital Limited:Kk センダイウイルス発現系を用いたサイトカインの製造方法
JP2000253876A (ja) * 1999-03-08 2000-09-19 Dnavec Research Inc センダイウイルスベクターを用いたワクチンおよびワクチンタンパク質
US20030022376A1 (en) * 1999-05-18 2003-01-30 Kaio Kitazato Paramyxovirus-derived RNP
CA2368944C (en) 1999-05-18 2010-07-27 Dnavec Research Inc. Paramyxovirus-derived rnp
US20020169306A1 (en) * 1999-05-18 2002-11-14 Kaio Kitazato Envelope gene-deficient paramyxovirus vector
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
ATE367445T1 (de) 1999-05-18 2007-08-15 Dnavec Research Inc Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen
EP1067179A1 (de) 1999-07-09 2001-01-10 Pierre Fabre Medicament Verfahren zur Selektion von attenuierten Paramyxoviridae verwenbare als Impstoffen und Therapeutika
CA2376106A1 (en) 1999-09-06 2001-03-15 Dnavec Research Inc. Paramyxoviruses comprising modified transcription start sequence
US7314614B1 (en) * 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
AU2001225487A1 (en) * 2000-01-19 2001-07-31 Dnavec Research Inc. Use of paramyxovirus vector in gene transfer into blood vessel
KR100854917B1 (ko) * 2000-03-30 2008-08-27 가부시키가이샤 디나벡크 겐큐쇼 센다이바이러스 벡터를 사용한 ａｉｄｓ 바이러스 백신
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
AU2001262684A1 (en) * 2000-06-01 2001-12-11 Dnavec Research Inc. Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity
AU2001266337A1 (en) * 2000-06-27 2002-01-08 Dnavec Research Inc. Virus vector for transferring gene into renal cells
CN1526014A (zh) * 2000-10-06 2004-09-01 ��ʽ���������о��� 用于将外源基因导入骨骼肌的副粘病毒载体
ES2305138T3 (es) * 2000-11-27 2008-11-01 Dnavec Research Inc. Vector de paramixovirus que codifica factor 2 de crecimiento de fibroblastos (fgf2) y uso del mismo.
WO2004038029A1 (ja) * 2002-10-24 2004-05-06 Dnavec Research Inc. T細胞に遺伝子を導入する方法
AU2004208057A1 (en) * 2003-01-31 2004-08-12 Dnavec Research Inc. Paramyxovirus vector encoding ribozyme and utilization thereof
JPWO2005001082A1 (ja) * 2003-06-30 2006-08-10 株式会社ディナベック研究所 高変異領域が改変された遺伝子を搭載するマイナス鎖ｒｎａウイルスベクター
CN1902312B (zh) * 2003-11-04 2011-02-23 株式会社载体研究所 制备导入了基因的树突细胞的方法
JPWO2005067981A1 (ja) * 2004-01-13 2007-12-27 株式会社ディナベック研究所 免疫刺激性サイトカインをコードするマイナス鎖ｒｎａウイルスベクターを用いる腫瘍の遺伝子治療
CN1957084A (zh) * 2004-03-23 2007-05-02 株式会社载体研究所 与组织的维持和/或修复相关联的骨髓相关细胞
EP1891215B1 (de) * 2005-04-20 2009-10-28 Dnavec Corporation Hochsichere intranasal verabreichbare genimpfstoffe zur behandlung von morbus alzheimer

Also Published As

Publication number Publication date
DE60118771D1 (de) 2006-05-24
KR100852078B1 (ko) 2008-08-13
CA2428073C (en) 2012-01-10
WO2002038726A2 (en) 2002-05-16
CA2428073A1 (en) 2002-05-16
HK1070100A1 (zh) 2005-06-10
DK1334174T3 (da) 2006-06-26
DE60118771T2 (de) 2007-04-12
CN1555417A (zh) 2004-12-15
AU2002212733A1 (en) 2002-05-21
EP1662003A2 (de) 2006-05-31
CN1555417B (zh) 2010-04-28
ES2260301T3 (es) 2006-11-01
EP1334174A2 (de) 2003-08-13
EP1334174B1 (de) 2006-04-12
KR20030074617A (ko) 2003-09-19
JP2002142770A (ja) 2002-05-21
EP1662003A3 (de) 2006-06-14
WO2002038726A3 (en) 2003-03-20
US20040101965A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
DE60118771D1 (de) Paramyxovirus-vektor zum gentransfer ins kardiovaskuläre system
DE69834908D1 (de) Verfahren zur erhöhung der expression von endogenen oder exogenen genprodukten in pflanzen
WO2001012824A8 (en) Means and methods for modifying gene expression using unpolyadenylated rna
ATE312192T1 (de) Verfahren zur fermentativen herstellung von aminosäuren und aminosäure-derivaten der phosphoglycerat-familie
ATE370229T1 (de) Ein verstärkter, durch viren vermittelter dna- transfer
ATE325533T1 (de) Verfahren zum verbesserten virusvermittelten dns- transfer unter verwendung von molekülen mit virus-und zellbindenden domänen
NO973745L (no) Nukleinsyreholdig preparat, dets fremstilling og anvendelse
ATE369435T1 (de) Paramyxoviren, die eine modifizierte transkriptionsstartsequenz umfassen
DE60126760D1 (de) Vektorkonstrukte
ATE325185T1 (de) Kultivierung von crypthecodinium cohnii und abstammenden microorganismen
DE60041553D1 (de) Verfahren zum trocknen von mikroorganismen
DE60018422D1 (de) Typ v pde-hemmer zur behandlung von mukoviszidose
MXPA02012255A (es) Secuencia de nucleotidos del genoma a/udorn/72(hen2) de influenza.
DE60041340D1 (de) Identifizierung des plasmodium falciparum erythrozn zum chondroitin sulfat a vermittelt
HRP20050424A2 (en) Process for making risperidone and intermediates thereof
MX9702316A (es) Procesos para la preparacion del acido ciclopropancarboxilico y sus derivados.
FR2813395B1 (fr) Methode de dosage in vitro de la fibrine soluble par generation de produits de degradation specifiques
AU6795201A (en) Nucleic acid sequences and methods for the modification of plant gene expression
WO2007125445A3 (en) An array of swim care articles and method for providing same to shopper and retailer
ATE428793T1 (de) Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten
HUP0204093A2 (hu) Ciroktörpítő gének és alkalmazásuk
NO20044687L (no) Tannborste
DK1283868T3 (da) Isoleret gum-operon fra Xyllela fastidiosa, isolerede nukleinsyremolekyler derfra og anvendelser deraf
DK1597376T3 (da) RNA-polymerase I-promotor fra höns samt anvendelse heraf
FR2814536B1 (fr) Enceinte a temperature regulee pour la conservation de produits notamment des bouteilles de vin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1334174

Country of ref document: EP

REN Ceased due to non-payment of the annual fee